Skip to content

Clinical observation of electroacupuncture combined with diclofenac sodium in the treatment of acute gouty arthritis

Clinical observation of electroacupuncture combined with diclofenac sodium in the treatment of acute gouty arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039458
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-06-01
Completion date
Unknown
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Interventions

Low-dose drug group:Diclofenac Sodium
EA combined drug group:Diclofenac Sodium + electroacupuncture treatment
Conventional drug group:Diclofenac Sodium

Sponsors

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Between 35-70 years old; 2. Male; 3. Meet the Clinical Classification Criteria for Gout arthritis made by EULAR and the standard of TCM damp-heat syndrome differentiation; 4. The lesion involved unilateral first metatarsophalangeal joint and / or other foot joints (non-first metatarsophalangeal joints) and / or ankle joint; 5. The acute attack was within 24 hours and VAS >= 4; 6. Patients agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Allergic to non-steroidal anti-inflammatory drugs; 2.Patients who have a taboo on acupuncture treatment; 3.Acupuncture treatment was taken within one week before the observation; 4.Any drugs for treating acute gouty arthritis were taken within one month before the observation; 5.Patients with active gastrointestinal diseases and patients with digestive tract ulcers 30 days before this study; 6.Patients with severe diseases in cardiovascular and circulatory system,dysfunction of liver and kidney,as well as mental illness.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Joint tenderness (0-3 point scale);Joint swelling (0-3 point scale);Activity limitation;Gout Impact Scale;Uric acid;White blood cell;Neutrophil%;C-reactive protein;Diclofenac sodium extra dosage;Diclofenac sodium extra dosing rate;Recurrence rate;Adverse events;

Countries

China

Contacts

Public ContactLiu Lumin

Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine

beefllm@163.com+86 13817684199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026